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The global transcriptional program of murine cytomegalovirus (MCMV), involving coding, noncoding, and
antisense transcription, remains unknown. Here we report an oligonucleotide custom microarray platform
capable of measuring both coding and noncoding transcription on a genome-wide scale. By profiling MCMV
wild-type and immediate-early mutant strains in fibroblasts, we found rapid activation of the transcriptome by
6.5 h postinfection, with absolute dependency on ie3, but not ie1 or ie2, for genomic programming of viral gene
expression. Evidence is also presented to show, for the first time, genome-wide noncoding and bidirectional
transcription at late stages of MCMV infection.
Murine cytomegalovirus (MCMV) is a ubiquitous betaher-
pesvirus with a 235-kbp genome transcribed in a classical cas-
cade fashion (55). The genome sequence of MCMV has been
available for some time (89), and yet a systematic study of
temporal gene expression during MCMV infection has been
lacking. Double-stranded PCR-based cDNA microarrays were
used once previously (105) to validate the expression of a
subset of predicted MCMV open reading frames (ORFs) (15)
at a single time point (24 h postinfection [hpi]). More-ad-
vanced microarray technology based on oligonucleotide
probes, affording increased specificity to distinguish RNA po-
larity, has not been reported. For human cytomegalovirus
(HCMV), abundant antisense (AS) transcription has been ob-
served (120), raising the possibility that aspects of the CMV
life cycle are influenced or regulated by noncoding transcripts.
For MCMV, small virus-encoded microRNAs (miRNAs) (19,
20, 33) and larger double-stranded RNAs (21, 110) have been
reported to be transcribed from multiple loci; however, the
frequency and abundance of noncoding transcripts throughout
the MCMV genome have not yet been measured systematically
on a genome-wide scale and at multiple stages of infection.
Here we have investigated the global transcriptional pro-
gram of MCMV by constructing a microarray capable of mea-
suring sense (S) and AS transcripts. Microarrays were designed
using 55-mer oligonucleotide probes in sense and antisense
orientations to each of the 170 viral ORFs predicted in the
MCMV genome (89). One hundred ninety-two positive-con-
trol probes were designed against stably expressed mouse
genes for normalization purposes, and 97 negative-control
probes were designed against Saccharomyces cerevisiae se-
quences with no homology to mouse or MCMV genomes (for
probe sequences, see Table S1 in the supplemental material).
The 55-mer oligonucleotide probes were diluted to a concen-
tration of 60 M and inkjet printed (Arrayjet, United King-
dom) onto amino silane-coated glass slides, with each microar-
ray consisting of six identical subarrays. Probes were printed in
triplicate per array and have the capacity for developing a total
of 18 measurements per probe per sample to ensure high
technical replication. Target RNA was extracted from infected
fibroblasts using PureLink RNA minikits with on-column
DNase I treatment (Invitrogen, CA). Purified RNA (700 ng for
each sample) was labeled for microarray analysis using the
Agilent low-input fluorescent linear amplification protocol
(Agilent, CA), with 3 g of Cy5-labeled target cRNA hybrid-
ized per sample. Hybridized microarrays were washed and
subsequently scanned using an Agilent (CA) G2505B scanner.
To perform a systematic analysis of genome-wide transcrip-
tion in MCMV, we infected NIH 3T3 fibroblasts with the
parental MCMV strain at a multiplicity of infection (MOI) of
1 and performed DNA microarray analysis on total RNA har-
vested from duplicate cultures at 0.5, 6.5, 24, and 48 hpi.
Individual probe signals were background subtracted, median
summarized, and log base 2 transformed to form raw data
points (see Table S2 in the supplemental material). Raw data
were quality controlled, and normalization between samples
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6068 NOTES J. VIROL.
was performed based on a subset of 44 positive-control probes
highly correlated across the data set (Pearson r of 0.90).
Normalized expression data (see Table S3 in the supplemental
material) were subjected to a statistically rigorous threshold
detection methodology for providing on/off calls for each
probe based on a receiver operating characteristic (ROC) (12).
From these ROC analyses, we evaluated specificity levels cor-
responding to given sensitivities of 70%, 80%, and 90%. At a
moderate sensitivity of 70%, we were able to obtain an average
specificity of 93%, and this was chosen as affording an optimal
balance between identifying true positives and excluding true
negatives with stringency (for ROC plots, see Fig. S1 and S2 in
the supplemental material). Accordingly, we detected 297 total
probes having “on” calls and 163 probes for coding MCMV
ORFs, making 87.6% of the MCMV genome detectable at 48
hpi (for a list of genes detected, see Table S4 in the supple-
mental material).
To account for experimental variation, statistical testing
(empirical Bayes moderated t test) was applied between mock-
infected and infected groups to identify differential expression
of only the most highly significant MCMV ORFs. By use of this
more stringent approach, 119 ORFs were found to be signifi-
cantly activated to a confidence level of P  0.05 above mock-
infected levels at all time points (Table 1). These included the
DNA polymerase subunit M54 (59), known inhibitors of major
histocompatibility complex class I (MHC-I) surface expression
m04 (gp34) (51) and m06 (gp48) (90), and the Fc receptor
m138 (108). After a single round of replication at 24 hpi, a total
of 111 MCMV ORFs were detected at the high significance
level. To further validate these findings, a subset of MCMV
ORFs were subjected to quantitative reverse transcription-
PCR (qRT-PCR) analysis (for primer sequences, see File S1 in
the supplemental material), and in agreement with the mi-
croarray results, each test case showed that ORF expression
was also detectable by qRT-PCR (Fig. 1a).
As previously noted for HCMV microarray analysis, there is
no overt positional bias toward expression of coding ORFs
based on genomic location that could be linked to the patterns
of gene expression observed during infection. MCMV ORFs
were annotated based on Rawlinson et al. (89) and updated
with details from additional publications wherever possible.
MCMV ORFs from recent predictions (15, 105) were aligned
against 55-mer probe sequences, identifying five probes over-
lapping with newly predicted ORFs (m107-m107.2, m16-
m16.2, m22-m22.1, M34-m34.2, and M58-m58.1), which were
reannotated accordingly.
As a result of the statistical cutoff (P 0.05), MCMV probes
for ORFs M44, M70, M75, m135, m143, m144, m153, and
m157 failed to be included, although these genes have been
reported to be expressed in previous MCMV studies or are
homologues of HCMV genes reported to be expressed (21, 29,
34, 79, 80, 89, 92, 110, 118). It is most likely that the specific
probes for these genes exhibit false-negative results. Neverthe-
less, in this study, we aimed to purposefully avoid false posi-
tives at the sacrifice of capturing a modest level of false neg-
atives. For this reason, we also did not detect ie1 or ie3
expression until 24 hpi based on the statistical cutoff; however,
these genes are detectable as early as 0.5 hpi and 2.5 hpi by use























































































































































































































































































































































































































































































































































































































VOL. 85, 2011 NOTES 6069
To gain further insight into the transcriptional programming
of MCMV, we next sought to profile gene expression from
three well-characterized MCMV mutants (5, 23, 36, 72) along-
side the parental MCMV strain (111) (for schematics of
strains, see Fig. 1b). To characterize the mutant strains before
microarray analysis, we sought to (i) determine equivalent in-
fectious doses at the genomic level by measuring genome/PFU
ratio for each stock, (ii) ensure that generating the ie3 deletion
mutant (MCMVdie3) in a complementing cell line did not
drastically alter the infectious-particle ratio, (iii) ensure that
viral growth phenotypes were consistent with those previously
published (5, 36, 72), and (iv) ensure that no viral transcription
was occurring from deleted loci. On the basis of quantitative
PCR (qPCR), we detected equivalent numbers of MCMV
genome copies per PFU for each viral strain (Fig. 1c), using as
a calibrator a reference plasmid containing the m115 (gL) gene
(nucleotides [nt] 166387 to 167208; GenBank accession no.
NC_004065) (for a detailed account of this approach, see ref-
erence 98). Equivalent numbers of MCMV genomes were also
found at 2 hpi inside cells infected with different MCMV
strains (data not shown). Multistep growth curves confirmed
viral growth phenotypes (see Fig. S4 in the supplemental ma-
terial), and qRT-PCR (Qiagen 1-step kit; Germany) confirmed
that transcription was not detectable from the respective de-
leted loci for ie1, ie2, and ie3 (data not shown). These data
show that the four MCMV strains are experimentally compa-
rable for downstream gene expression analysis.
Based on previous virologic characterization of these
MCMV immediate-early (IE) mutants, we expected to observe
different gene expression profiles for the MCMV strains. For
example, given that removal of the ie2 gene causes no reported
change in phenotype (45), we anticipated few gene expression
changes in the MCMVdiie2 strain relative to the parental
MCMV strain. Alternatively, given that ie3 has an indispens-
able regulatory function and is essential for viral growth (5), we
expected little or no viral gene expression to be detectable
from the MCMVdie3 strain. However, for the ie1 deletion
mutant (MCMVdie1), the expectation was less clear, given that
this strain has wild-type growth characteristics and yet the IE1
protein is well known to have transcriptional regulatory activity
(24, 39, 76) and is further known to interact with cellular host
factors (81, 104). In order to profile the gene expression of
each mutant strain, we infected NIH 3T3 fibroblasts in parallel
at an MOI of 1 and harvested total RNA for microarray anal-
FIG. 1. MCMV ORF detection and characterization of MCMV IE deletion mutant strains. (a) (Panel i) Microarray signals for 10 MCMV
ORFs in mock- and MCMV-infected cells. (Panel ii) qRT-PCR validation of the 10 MCMV ORFs at 24 hpi. The y axis represents crossing point
(Cp) values from qPCR amplification curves, with low Cp values indicating high transcript abundance. Error bars represent standard errors of the
mean. (b) Schematic representations of recombinant MCMV IE deletion mutants. The map of the parental MCMV genome is shown at the top,
with structures of the ie1, ie2, and ie3 transcripts below. Coding exons are shown in black, with arrows indicating the directions of transcription,
and white triangles represent deleted loci. The gray box marks the MCMV ie1/ie3 promoter enhancer (MIEP). (Line iii) The MCMVdie3 revertant
strain was renamed MCMVdiie2 in this study, as the HCMV MIEP is inserted between two HpaI sites spanning the transcription start site of the
ie2 gene, disrupting ie2 expression (marked with ). GFP, green fluorescent protein. (c) Viral titers and genome particle/PFU equivalences of the
four MCMV strains, as determined by qPCR.
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ysis at 0.5, 6.5, and 48 hpi, along with that of mock-infected
cells.
Figure 2 shows the comparative activation of viral transcrip-
tomes among the four MCMV strains at 48 hpi and indicates that
the transcriptomes of MCMVdie1 and MCMVdiie2 are activated
with profiles of viral gene expression very similar to that of the
parental MCMV strain over the 48-h period (Fig. 2a). Similar
numbers (within 10%) of MCMV probes were detectable from
MCMVdie1 (103 ORFs), MCMVdiie2 (114 ORFs), and the
parental strain (113 ORFs) at 48 hpi. The degree of similarity in
expression profiles among the MCMVdie1, MCMVdiie2, and
parental MCMV strains suggests that ie1 and ie2 have a
redundant or negligible transcriptional regulatory role in
controlling downstream MCMV gene expression during fi-
broblast infection. Hierarchical clustering (Fig. 2b) further
indicates few, if any, differences in the global gene expres-
sion profiles of MCMVdie1 and MCMVdiie2 compared to
that of the parental MCMV strain. These results could point
to a redundant role for the ie1 and ie2 genes in controlling
downstream viral gene expression or, alternatively, a lack of
FIG. 2. Gene expression program of MCMV, MCMVdie1, MCMVdiie2, and MCMVdie3. (a) Volcano plots comparing microarray signals
from mock-infected and infected samples at 48 hpi, using P value (y axis) and fold change (FC) (x axis) comparisons derived from empirical Bayes
testing, with two biological replicates per group. (b) Hierarchical clustering of high-confidence MCMV probes, with each row representing a single
probe normalized to its mean value across the data set to show relative expression. Yellow indicates increased expression and blue indicates
decreased expression relative to the mean. Genes clustered based on the similarity of their expression profiles across the data set, with similar genes
connected at the hierarchical tree on the left. Data represent mean values from two biological replicates. Numerical values at top indicate hours
postinfection.
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sensitivity in controlling the viral genomic program in fully
permissive fibroblasts.
In marked contrast to the ie1 and ie2 mutant strains,
MCMVdie3 exhibited an undetectable level of viral gene ex-
pression, suggesting that ie3 acts as a global trans-activator of
downstream MCMV gene expression, as indicated by previous
studies (5). To further examine the transcriptional status of
MCMVdie3 using a more sensitive approach, IE and down-
stream MCMV genes were measured using qRT-PCR in
MCMVdie3-infected cells both in the presence and in the
absence of 50 g/ml cycloheximide (C7698; Sigma, United
Kingdom) at 2.5 hpi. These experiments confirmed that IE
kinetic class genes were expressed in MCMVdie3 but that
genes beyond the IE region were not (see Fig. S5 in the sup-
plemental material).
The design of the MCMV microarray platform enables se-
lective detection of transcripts originating from both strands of
the viral genome by having probes designed in sense (S) and
antisense (AS) orientations to each MCMV ORF. At 24 hpi,
we detected antisense transcripts from 23 AS loci, five of which
(m104as, M113as, m147as, m163as, and m168as) have overlap-
ping ORFs on the opposite strand of the genome, indicating
known or predicted regions of bidirectional transcription based
on prior annotation (105). Three other loci were found to have
neighboring but nonoverlapping ORFs in their vicinity (M57as,
m74as, and M88as). An additional 15 MCMV AS probes de-
tected at 24 hpi were found to have no overlapping or nearby
ORFs located on the opposite strand, indicating previously
unknown noncoding transcripts derived from regions outside
MCMV ORFs (m04as, m05as, m06as, m07as, m09as, m13as,
m41as, M47as, M50as, M87as, M102as, M115as, m119.2as,
m124as, and m145as). At 48 hpi, an additional eight antisense
probes were detectable, but all have overlapping or nearby
ORFs on the opposite strand of the genome (M48as, m69.1as,
M89as, M94as, m108as, m119.3as, m132as, and m144as). In
total, evidence of antisense transcription was detected from 35
loci over the four time points as measured by microarray anal-
ysis (Table 2 and Fig. 3). Twenty-six of these loci were also
TABLE 2. High-confidence MCMV microarray antisense probesa
Unique probe IDb ORF Time onc (hpi) Details of cDNA cloning validation Sense probed
vMC336 m148as 6.5 Validated with AS cDNA clone L151 at nt 208012 to 207467 (5 to 3),
overlapping m148 (AS) and m149 (S); clone length, 545 nt
S
vMC357 m169as 6.5 S
vMC175 m05as 24 S
vMC180 m163as 24 S
vMC188 m04as 24 Validated with AS cDNA clone IE150 at nt 4043 to 3943 (5 to 3),
overlapping m04 (AS); clone length, 384 nt
S
vMC189 m05as 24 S
vMC190 m06as 24 S
vMC191 m07as 24
vMC193 m09as 24
vMC197 m13as 24 S
vMC229 m41as 24 S
vMC236 M47as 24
vMC241 M50as 24 S
vMC248 M57as 24 S
vMC257 m74as 24 Validated with AS cDNA clone L147 at nt 104825 to 105449 (5 to 3),
overlapping m74 (AS); clone length, 624 nt
S
vMC269 M87as 24
vMC270 M88as 24 S
vMC283 M102as 24 S
vMC285 M104as 24
vMC291 M113as 24 S
vMC293 M115as 24 S
vMC299 m119.2as 24 S
vMC311 m124as 24 S
vMC333 m145as 24 S
vMC335 m147as 24
vMC351 m163as 24 S
vMC356 m168as 24 S
vMC239 M48as 48 S
vMC251 m69.1as 48
vMC272 M89 Ex2as 48
vMC277 M94as 48 Validated with AS cDNA clone L164 at nt 137299 to 137096 (5 to 3),
overlapping m94 (AS); clone length, 203 nt
S
vMC289 m108as 48 S
vMC300 m119.3as 48 S
vMC319 m132 Ex2as 48 S
vMC332 m144 48
a Microarray probes for antisense transcripts found to be significantly upregulated in MCMV-infected cells versus mock-infected cells to a high confidence level (P
0.05 by empirical Bayes analysis).
b Probe ID, probe identifier.
c Time on, time detected.
d AS probes with significant signal also found from the corresponding sense probes are marked with an “S.”
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found to have significant signal from the corresponding sense
(S) probe, indicating a potential site of bidirectional transcrip-
tion. A trend toward antisense transcription occurring more
frequently at the terminal ends of the MCMV genome is also
noted (Fig. 3).
In order to independently validate AS transcripts identified
by microarray analysis, we generated cDNA libraries from
MCMV-infected fibroblasts pooled from 4, 8, and 12 hpi (IE
library), 16, 24, and 32 hpi (E library), or 40, 60, 80, and 100 hpi
(L library). cDNA libraries were generated as described pre-
viously for HCMV (120). cDNA clones overlapping AS mi-
croarray regions were found at m04as, m74as, M94as (none of
which have overlapping ORFs on the opposite strand of the
genome), and m148as (which has the m147 ORF on the op-
posite strand of the genome) (for validated AS transcripts, see
Table 2). We also found one large cDNA clone that over-
lapped three MCMV ORFs (m119.2, m119.3, and m119.4),
two of which had potential AS regions identified by microarray
probes (m119.2 and m119.3). Four additional AS cDNA clones
were found to overlap AS regions not identified by microarray
analysis (m19as, M72as, m149as, and m151as). These experi-
ments thus reveal for the first time that antisense transcription
occurs frequently throughout the MCMV genome, an obser-
vation that will likely seed further studies.
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